Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21174096.
- Also identified by DOI 10.1007/s00330-010-2033-y and PMC identifier 3032196.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the last decade, PET-only systems have been phased out and replaced with PET-CT systems. This merger of a functional and anatomical imaging modality turned out to be extremely useful in clinical practice. Currently, PET-CT is a major diagnostic tool in oncology. At the dawn of the merger of MRI and PET, another breakthrough in clinical imaging is expected. The combination of these imaging modalities is challenging, but has particular features such as imaging biological processes at the same time in specific body locations.
Medical subject headings
- Magnetic Resonance Imaging
- Medical Oncology
- Molecular Imaging
- Neoplasms
- Positron-Emission Tomography
- Subtraction Technique
- Tomography, X-Ray Computed